Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for GeoVax Labs (GOVX) over the last 16 years, with Q3 2025 value amounting to $16802.0.

  • GeoVax Labs' Depreciation & Amortization (CF) fell 4474.48% to $16802.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $72167.0, marking a year-over-year decrease of 2477.9%. This contributed to the annual value of $95368.0 for FY2024, which is 2858.2% up from last year.
  • GeoVax Labs' Depreciation & Amortization (CF) amounted to $16802.0 in Q3 2025, which was down 4474.48% from $16803.0 recorded in Q2 2025.
  • GeoVax Labs' Depreciation & Amortization (CF)'s 5-year high stood at $30408.0 during Q3 2024, with a 5-year trough of $4517.0 in Q1 2021.
  • For the 5-year period, GeoVax Labs' Depreciation & Amortization (CF) averaged around $16572.0, with its median value being $16921.0 (2025).
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first surged by 35442.66% in 2021, then crashed by 4474.48% in 2025.
  • Over the past 5 years, GeoVax Labs' Depreciation & Amortization (CF) (Quarter) stood at $11715.0 in 2021, then grew by 20.11% to $14071.0 in 2022, then surged by 57.86% to $22213.0 in 2023, then dropped by 2.58% to $21641.0 in 2024, then decreased by 22.36% to $16802.0 in 2025.
  • Its Depreciation & Amortization (CF) stands at $16802.0 for Q3 2025, versus $16803.0 for Q2 2025 and $16921.0 for Q1 2025.